Yeah...tick...tick...tick...trials dont lie whether performed in US or Germany...
Too bad there were no FDA sanctioned trials which ever occurred in Germany.
BTW - how many 2nd line patients were in the Lohr studies? Why did the two patients that Lohr claims had a partial response, then live for shorter times than some of those with stable disease? Where stable disease is less of a response than partial response. And how was stable disease defined, and then measured after 20 weeks, when it wasn't. When did Lohr ever run a control arm of Metronomic Ifosfamide vs Metronomic Ifosfamide + CIABs? He didn't. Many more questions. It was a faulty study per today's FDA standards.
News 
Market Data 
Discover 
